Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Dec 22:2017:bcr2017221530.
doi: 10.1136/bcr-2017-221530.

Double hit! A unique case of resistant hypertension

Affiliations
Case Reports

Double hit! A unique case of resistant hypertension

Kristen Elizabeth DeCarlo et al. BMJ Case Rep. .

Abstract

A middle-aged woman with obesity, hyperlipidaemia and diet-controlled diabetes was referred for resistant hypertension. Her blood pressure (BP) was uncontrolled on five medications, including a diuretic. Physical exam revealed a systolic ejection murmur, and ECHO demonstrated moderate hypertrophy. Laboratory examination revealed elevated aldosterone level (20.7 ng/dL) and elevated aldosterone:renin ratio (41.4 (ng/dL)/(ng/mL/h)), meeting criteria for primary aldosteronism (PA), and confirmed by saline infusion testing. CT scan of the adrenals was non-localising. Adrenal venous sampling confirmed bilateral idiopathic adrenal hyperplasia. Concurrent primary hyperparathyroidism was demonstrated by elevated calcium and parathyroid hormone levels and localised by sestamibi scan. Idiopathic adrenal hyperplasia was treated medically with spironolactone. Her BP remained elevated until postparathyroidectomy. Evidence shows that a hyperfunctioning parathyroid gland may contribute to maintaining hyperaldosteronism in PA making this bidirectional link unique. The significance of this case is in the potential for further understanding of the pathophysiology of common causes of secondary hypertension.

Keywords: adrenal disorders; drugs: endocrine system; endocrinology; hypertension.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Time course of the clinical case.Normal ranges: aldosterone (aldo)=3–15 g/dL; calcium (Ca)=8.0–10.4 mg/dL; ionised calcium (iCa)=4.6–5.2 mg/dL; parathyroid hormone (PTH)=14–72 pg/mL; plasma renin=0.65–5.0 ng/mL/h. Upward arrow indicates increased medication dose.  ACE, lisinopril; AML, amlodipine; Carved, carvedilol; Chlor, chlorthaldone; HCTZ, hydrochlorothiazide; Hydral, hydralazine; IAH,  idiopathic adrenal hyperplasia; Labet, labetalol; Lat index, lateralis ation index; Nifed, nifedipine; PA,  primary aldosteronism; PPTH,  primary hyperparathyroidism; Ptx, parathyroidectomy; Renin, plasma renin; Spiro, spironolactone.
Figure 2
Figure 2
Non-contrast CT abdomen and pelvis. The liver, spleen, and pancreas are unremarkable. Normal appearance of the bilateral adrenal glands at the level of the suprarenal fossa. There is no evidence of adrenal mass or cyst. Arrow identifies location of the adrenal gland.

References

    1. Funder JW, Carey RM, Mantero F, et al. . The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016;101:1889–916. 10.1210/jc.2015-4061 - DOI - PubMed
    1. Rossi GP, Bernini G, Caliumi C, et al. . A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293–300. 10.1016/j.jacc.2006.07.059 - DOI - PubMed
    1. Milliez P, Girerd X, Plouin PF, et al. . Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243–8. 10.1016/j.jacc.2005.01.015 - DOI - PubMed
    1. Yeh MW, Ituarte PH, Zhou HC, et al. . Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 2013;98:1122–9. 10.1210/jc.2012-4022 - DOI - PMC - PubMed
    1. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(Suppl 2):N18–23. - PubMed

Publication types

MeSH terms

LinkOut - more resources